Industry News

AV Laboratories To Participate in the 2025 ICR Conference

The skincare brand will offer a skin scan using VISIA Skin Analysis System at the Marriott & Ritz Carlton Resort in Orlando, FL on Jan. 13 and 14, 2025.

Author Image

By: Lianna Albrizio

Associate Editor

Skin longevity brand AV Laboratories will participate in the 2025 ICR Conference at the JW Marriott & Ritz Carlton Resort in Orlando, FL on Jan. 13 and 14, 2025.

The brand’s molecular skin care system was developed by a global team of scientists and led by biotech leaders, CEO and Co-Founder Ami Mezezi; Co-Founder and Advisory Board Chairwoman Monica Mezezi; and Co-Developer and COO Sylwia Pawlaczyk, who will be on-site.

Skin Analysis System

AVL will offer a skin scan using VISIA Skin Analysis System at the conference. The VISIA is a specialized device used in dermatology to analyze and visually assess the condition of a person’s skin by capturing detailed facial images using different lighting techniques, allowing practitioners to identify issues like wrinkles, sun damage, pores, texture and pigmentation irregularities. Once the skin is analyzed, the AV Laboratories team will provide insights and suggestions on what products make the most sense for each person’s needs.

Dual-Action Formulation

All AVL products consist of a dual-action formulation containing AVL SOM3, the brand’s patented longevity technology, and clinical-grade actives, formulated to work with skin to target specific concerns including the appearance of fine lines and wrinkles, dark spots, hyperpigmentation, redness, uneven skin tone and dryness.

AVL SOM3 provides daily skin nutrition on the molecular level, per makers. It’s designed to support NAD+ levels and increase skin rejuvenation while increasing barrier function and lowering cellular damage.

Keep Up With Our Content. Subscribe To Happi Newsletters